| Esopus Dental, Pc | |
|
105 Woodcrest Drive Rifton NY 12471 | |
| (845) 658-8131 | |
| Not Available |
| Full Name | Esopus Dental, Pc |
|---|---|
| Speciality | Dentist - General Practice |
| Location | 105 Woodcrest Drive, Rifton, New York |
| Authorized Official Name and Position | Josef Loewenthal (VICE PRESIDENT) |
| Authorized Official Contact | 8454817014 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Esopus Dental, Pc 10 Hellbrook Lane Ulster Park NY 12487 Ph: (845) 481-7014 | Esopus Dental, Pc 105 Woodcrest Drive Rifton NY 12471 Ph: (845) 658-8131 |
| NPI Number | 1508885898 |
|---|---|
| Provider Enumeration Date | 07/18/2006 |
| Last Update Date | 01/13/2022 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508885898 | NPI | - | NPPES |
| 02532218 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 52863 (New York) | Primary |
News Archive
An attentive, nurturing mother may be able to help her children better resist the temptations of drug use later in life, according to a study involving the University of Adelaide.
As part of an initiative to give back to cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is recognizing The Center for Cancer Support and Education (The Center) in Arlington, Mass., for its efforts to empower and support people touched by cancer, their caregivers and loved ones.
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.
Hercules Technology Growth Capital, Inc., the leading specialty finance company providing venture debt and equity to venture capital and private equity-backed technology and life science companies at all stages of development, today announced that it has recorded gross realized proceeds on the sale of Gomez, Inc., one of its portfolio companies, to Compuware Corporation of $1.7 million.
› Verified 4 days ago